Latest Administration News

Qoria Limited marked a turning point in FY25, delivering 25% growth in Annual Recurring Revenue and a 684% jump in underlying EBITDA, setting sights on 20% EBITDA margin in FY26 amid global digital safety expansion.

Alara Resources (ASX:AUQ) is seeking to raise $3.84 million through a pro-rata non-renounceable entitlement offer, partially underwritten by major shareholder ATI. The funds will primarily support exploration and working capital amid ongoing operational progress at its Oman copper projects.

QPM Energy Limited and its subsidiaries have entered voluntary administration with McGrathNicol appointed as administrators and FTI Consulting as receivers over key gas-producing entities. The move aims to stabilise operations and explore restructuring options amid ongoing financial distress.

Marquee Resources (ASX:MQR) is raising just over $1 million through a non-renounceable rights issue priced at half a cent per share, accompanied by free attaching options. The capital raise aims to support ongoing exploration and the recent acquisition of the Tungsten Mountain Project in Nevada.

Legend Mining advances gold exploration at its Pinnacle Well Project, confirming extensive hydrothermal alteration and coincident IP anomalies at Pyrophyllite Hill and Alpha North, with drilling set to follow heritage surveys.

Alterity Therapeutics has secured official FDA confirmation that a single pivotal Phase 3 trial, backed by prior Phase 2 data, can support approval of ATH434 for Multiple System Atrophy. Trial initiation remains on track for late 2026.

The Supreme Court of New South Wales has approved the scheme of arrangement for Rubik Australia to acquire Qube Holdings, setting the stage for trading suspension and ownership transfer.

Noxopharm has taken a key regulatory step by requesting a pre-IND meeting with the US FDA for its autoimmune drug candidate SOF-SKN, aiming to smooth the path for clinical development and boost its commercial appeal.

Botanix Pharmaceuticals has received an Intention to Grant from the European Patent Office for a patent protecting its Sofdra applicator technology, potentially extending exclusivity in Europe until 2039.

Zoono Group has reported a 94% jump in quarterly cash receipts to NZ$975K, turning cash flow positive amid expanding commercial rollouts of its shelf-life extension technology across multiple continents.

Netwealth has broadened its partnership with Morgan Stanley Wealth Management Australia by providing a new domestic platform for ASX equities and investments, underpinning robust FY26 fund inflows and an optimistic FY27 outlook.

Electro Optic Systems (ASX:EOS) has acknowledged a delayed disclosure of CEO Dr Andreas Schwer’s share rights and options, attributing it to an administrative oversight despite existing compliance protocols.